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Sensitized CD4+ T cells play an essential role in delayed type hypersensitivity (DTH) elicited by HSV-1 antigen. As activated CD4+
T cells express CXCR3, we investigated whether this chemokine receptor was involved in their recruitment. Antibody blockade of
CXCR3 suppressed DTH, whereas ear pinna swelling was not impaired in mice lacking the gene for CCR5, another frequently
expressed chemokine receptor. CXCR3 ligands IP-10 and Mig were elevated at the DTH site. Their neutralization significantly reduced
DTH ear swelling and CD4+ T cell influx. Furthermore, CXCR3 ligand expression was abrogated and DTH diminished in mice unable
to make IFN-g, a potent inducer of IP-10 and Mig. Interestingly, neutralization of CXCR3 or its ligands did not compromise host
resistance to virus replication. Collectively, these results suggest that in the sensitized host, CXCR3, IP-10, and Mig are required for
optimal DTH responsiveness but are not essential for containing HSV-1 replication in the ear pinna.
D 2005 Elsevier Inc. All rights reserved.
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Hosts exposed to a viral antigen upon re-exposure may
manifest a vigorous inflammatory response termed delayed
type hypersensitivity (DTH). This phenomenon can be
initiated by inoculation of HSV-1 antigen into the ear pinna
of sensitized mice (Schrier et al., 1982). The ensuing
inflammation is brought about in part by proinflammatory
molecules called chemokines which recruit various leuko-
cytes to the site of antigen deposition. Previous studies in
our laboratory (Tumpey et al., 2002) and others (Kudo et al.,
1993; Larsen et al., 1995) have shown that neutrophils are
one of the essential cellular components of the inflammatory0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.01.005
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E-mail address: rlausch@jaguar1.usouthal.edu (R. Lausch).cascade. In the ear pinna model, sensitized animals depleted
of neutrophils 24 h before antigen challenge displayed a
significant reduction in DTH (Tumpey et al., 2002). The
chemokines MIP-2 and MIP-1a were identified as recruiters
of the neutrophils.
The sensitized CD4+ T lymphocyte of the Th 1 phenotype
(Hendricks and Tumpey, 1990; Nash and Gell, 1983; Newell
et al., 1989) has been found to be the cell responsible for
initiating the DTH response to HSV-1 viral antigen.
Presently, it is not known which chemokine receptors and
ligands coordinate this cell’s recruitment. Activated Th1
cells preferentially express CXCR3, (Bonecchi et al., 1998;
Sallusto et al., 1998) a member of the super-family of seven-
transmembrane segment G protein-coupled receptors (Lu
et al., 1999). This receptor and its ligands IFN-g inducible
protein 10 (IP-10/CXCL10) and monokine induced by
IFN-g (Mig/CXCL9) have been associated with a number2005) 1–9
Fig. 1. CXCR3 but not CCR5 is required for optimal DTH response to
HSV-1 antigen. Balb/c mice were sensitized topically on day 0 with 1  104
PFU HSV-1. (A) On day 11, DTH challenge was performed by ear pinna
inoculation of 1  105 PFU HSV-1 admixed with 63 Ag of rabbit anti-
CXCR3 antibody or rabbit IgG. A further 70 Ag of antibody or control IgG
was administered at the DTH site 11 h later. (B) CCR5 receptor knock out
and wildtype (WT) mice (C57Bl/6 background) were sensitized and
challenged as in (A) without antibody treatment. The DTH response was
monitored by ear swelling measurement 24 h post-challenge.
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2001). These chemokines are reported to be secreted by
human neutrophils (Gasperini et al., 1999) and thus may be
candidates for T cell recruitment to the DTH site.
IP-10 and Mig are structurally and functionally related,
directing the migration of selected murine lymphocytes, in
particular activated T cells (Farber, 1997) following binding
to CXCR3. However, although both chemokines bind
CXCR3, a number of observations suggest that Mig and
IP-10 are not necessarily functionally redundant in vivo. For
example, Mig cannot substitute for IP-10 which is required
for murine survival following Toxoplasma gondii infection
(Khan et al., 2000). It also has been shown that antibody
neutralization of IP-10 but not Mig was protective in the
chronic phase of CNS disease in a murine model of viral
hepatitis (Liu et al., 2001a, 2001b).
In the present study, we tested the hypothesis that
CXCR3, IP-10, and/or Mig were essential participants in
DTH to viral antigen. The experimental approach was to test
what effect passively transferred neutralizing antibody had
on ear swelling. The results indicated that CXCR3 and both
ligands were needed for optimal DTH responsiveness.
Additional support for this conclusion came from experi-
ments conducted in mice lacking the gene for IFN-g, the
principal inducer of IP-10 and Mig (Farber, 1997). We also
investigated whether CXCR3 and its ligands were needed
for HSV-1 clearance from the DTH site.Fig. 2. Expression of IP-10 and Mig at the DTH site. Balb/c mice were
sensitized on the scarified cornea with 1  104 PFU HSV-1. Seven days
later, ear pinnae were challenged with 1  105 PFU HSV-1. Individual ear
pinna was removed 24 h post-challenge and tissue lysates prepared.
Chemokine levels were quantitated by ELISA.Results
Role for CXCR3 but not CCR5 in DTH to a viral antigen
We initially tested whether CXCR3 was an essential
component in the development of DTH. To this end micewere given anti-CXCR3 antibody in the ear pinna at the
time of antigen challenge and again 11 h later. The antibody
used was previously shown to suppress inflammation in a
mouse model of bronchiolitis obliterans syndrome (Belperio
et al., 2002). Fig. 1A shows that local antibody treatment
produced a marked decrease (69% reduction) in the ear
swelling response relative to the IgG treated controls 24 h
post-antigen challenge. CCR5 is also known to be a
prominent chemokine receptor on T cells of the Th1
phenotype (Loetscher et al., 1998). To evaluate the
contribution of CCR5, animals with a defective gene for
this receptor were used. Fig. 1B shows that mice lacking
CCR5 did not manifest a significant reduction in ear
swelling (P N 0.7) in comparison to the wildtype controls.
This result, representative of three independent experiments,
indicates that unlike CXCR3 CCR5 is not an essential
participant in DTH.
Expression of IP-10 and Mig at the DTH test site
Since CXCR3 was needed for an optimal DTH response
we hypothesized that its ligands should be present at the site
of antigen disposition. To test this hypothesis, ear lysates
prepared 24 h after antigen challenge were assayed for IP-10
and Mig. Fig. 2 shows that both chemokines were readily
detected. IP-10 was moderately but significantly elevated
(2-fold) above the level found in unsensitized hosts, whereas
Mig was 15-fold higher in the immunized mice. In normal
ears, not virus challenged, constitutive levels of IP-10 were
seen in 2 out of 10 ear pinnae tested, while no Mig (b3 pg/
ml) was detected in any of the 10 ear preparations examined
(data not shown).
Antibody neutralization of IP-10 and Mig suppresses DTH
The presence of a chemokine at the site of inflammation
does not establish that it is an essential participant in DTH.
To investigate chemokine functionality sensitized mice were
challenged with HSV-1 antigen admixed with 36 Ag
Fig. 3. Effect of IP-10 neutralization on the DTH response. On day 7 after sensitization Balb/c mice were challenged in the ear pinna with 1  105 PFU HSV-1
together with 36 Ag (A) or 67 Ag (B) of anti-IP-10 antibody. Ear swelling was measured 24 h post-challenge after which a 5-mm2 section of tissue from the
DTH site was harvested, lysates prepared, and assayed by ELISA for the indicated chemokines. Samples from the low dose experiment are shown (C and D).
The groups with the asterisk were significantly different ( P b 0.04) from the IgG-treated immune control.
Table 1
Leukocyte counts in ear pinnae of anti-chemokine-treated micea
Leukocytes Naive Immunized
Goat IgG Anti-IP-10 Pb
CD4+ T cells 38 F 4b 60 F 5 14 F 2 0.05
CXCR3+ cells 3 F 2 13 F 3 3 F 2 0.0001
Neutrophils 87 F 6 115 F 6 131 F 8 NS
a Ear pinnae (two per group) of sensitized or naive mice were challenged
with 1  105 PFU HSV-1 admixed with neutralizing antibody or control
IgG as described in Materials and methods.
b Designated cell populations were counted in six different 40 fields
in each of two sections from each tissue (24 fields in total). Mean cell
counts F SE are shown. P values represent a significant difference
between the anti-IP-10 antibody treated group and the IgG control
group. NS indicates no significant difference.
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challenge ear swelling was measured. Fig. 3A shows that
this dose of antibody to IP-10 moderately but significantly
reduced ear swelling (23% reduction) relative to that of the
IgG controls. Administration of a higher antibody dose (67
Ag) produced a greater decrease in ear swelling (69%
reduction) relative to the IgG controls (Fig. 3B). Analysis of
ear pinna lysates confirmed that IP-10 was neutralized as the
chemokine level was reduced by 74% (Fig. 3C). Fig. 4A
shows that when the test antigen inoculum was admixed
with 40 Ag antibody to Mig DTH was suppressed by 59%.
Anti-Mig treatment reduced Mig levels in ear pinna lysates
by 46% (Fig. 4C). Although neutralization of either
chemokine significantly reduced ear swelling during DTH
the inflammatory responses were not reduced to the level
observed in the naive unsensitized mice (Figs. 3A and 4A).
Passively transferred antibody to IP-10 did not neutralize or
significantly up-regulate the level of Mig in vivo (Fig. 3D)
nor did antibody to Mig neutralize or significantly up-
regulate the level of IP-10 (Fig. 4B). Collectively, these
results indicate that both IP-10 and Mig are required for
optimal DTH responsiveness.
T cell recruitment to the DTH site is reduced by antibody
neutralization of IP-10
To directly assess whether local anti-IP-10 treatment
altered leukocyte influx into the DTH site ear pinnae wereexamined histologically. Table 1 shows that infiltration of
CD4+ T cells was markedly diminished (77% reduction).
Similarly, anti-IP-10 treatment also reduced CXCR3+ cell
migration into the DTH site by 77%. As anticipated, the
influx of neutrophils was unaffected by IP-10 neutralization.
Influence of IFN-c on DTH response and chemokine
production
IFN-g is required for optimal DTH responsiveness
(Bouley et al., 1995), and is also known to be a potent
inducer of IP-10 and Mig (Farber, 1997). We tested the
hypothesis that mice with a disrupted IFN-g gene would
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reduced DTH response. As expected, absence of IFN-g
was associated with a marked reduction (53% decrease) in
ear swelling (Fig. 5A). Fig. 5B shows that substantial levels
of IFN-g were present in the ear pinna lysates of wildtype
hosts but absent in those of IFN-g/ mice 24 h after virus
challenge. We then tested whether the absence of IFN-g
influenced IP-10 and Mig expression at the DTH site.
Strikingly, neither IP-10 nor Mig could be detected in the
lysates of ear pinnae obtained from the IFN-g/ hosts
whereas nanogram levels of each chemokine were detected
in the ear pinnae of wildtype hosts (Figs. 5C and D). Thus,
disruption of the IFN-g gene correlated with absence of
IP-10 and Mig and reduced ear pinna swelling.
Effect of neutralizing antibody to CXCR3, IP-10, and Mig
on HSV-1 growth at the DTH site
Since antibody neutralization of CXCR3 or its ligands
suppressed DTH, we investigated whether antibody treat-
ment also impaired the sensitized host’s ability to suppress
HSV-1 replication following ear pinna challenge. Ear
pinnae were excised 24 h after HSV-1 challenge and
tissue lysates thereof were assayed for infectious virus
content. The results are shown in Figs. 6A, B, and C. ItFig. 4. Effect of Mig neutralization on the DTH response. On day 7 after sensitizat
together with 40 Ag of anti-Mig antibody. Ear swelling was measured 24 h post-c
harvested, lysates prepared, and assayed by ELISA for the indicated chemokines (B
from the IgG-treated immune control.was found that the virus titers in the antibody treated hosts
were not significantly different from the IgG treated
controls. Thus, antibody treatments which clearly sup-
pressed DTH and T cell infiltration failed to impair anti-
viral resistance. Sensitized mice with a disrupted IFN-g
gene also were not impaired in their ability to contain virus
growth (Fig. 6D).Discussion
The chemokine system consists of numerous receptors
and their ligands. Thus, the challenge is to determine which
receptors and which ligands play an essential role in a given
inflammatory response. In this study, we show that CXCR3
is an essential participant in the elicitation of DTH to HSV-1
antigen. Sensitized hosts treated locally with neutralizing
antibody to CXCR3 displayed significantly reduced ear
pinna swelling. Moreover, antibody to CXCR3 ligand IP-10
suppressed the infiltration of CXCR3+ cells and CD4+ T
cells at the DTH site. These findings conform with studies
showing that CXCR3 expressing effector T cells are readily
observed in a number of inflammatory skin conditions
including lichen planus, psoriasis, and allergic contact
dermatitis (Flier et al., 2001; Klunker et al., 2003; Tokurikiion, Balb/c mice were challenged in the ear pinna with 1  105 PFU HSV-1
hallenge (A) after which a 5-mm2 section of tissue from the DTH site was
and C). The groups with the asterisk were significantly different ( P b 0.04)
Fig. 5. CXCR3 ligand production in the IFN-g/ host. Ear pinnae from sensitized and naive IFN-g/ mice (Balb/c background) were collected 24 h
after 1  105 PFU HSV-1 challenge. Ear swelling was measured and tissue lysates prepared and assayed for the indicated agent by ELISA. The groups
with the asterisk were significantly different ( P b 0.01) from the sensitized wildtype control group.
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mediated blockade of CXCR3 can result in diminished T
cell migration into inflamed tissues including the perito-
neum, footpad, lung, and cardiac allograft (Belperio et al.,
2002; Hancock et al., 2000; Xie et al., 2003).Fig. 6. IP-10, Mig, CXCR3 and IFN-g are not required to contain virus growth in
challenged with 1  105 PFU HSV-1 admixed with the indicated antibody (36 Ag a
70 Ag of anti-CXCR3 antibody was administered locally 11 h later. IFN-g knock
were prepared and assayed for infectious virus content via plaque assay. IndividuCCR5, like CXCR3, is expressed by type 1 T cells, and
has also been found to be present in inflamed skin (Jiankuo
et al., 2003; Kunkel et al., 2002). Thus, one might anticipate
that this receptor would also be required for optimal ear
swelling. However, we found that DTH was not signifi-sensitized hosts. Seven to 11 days after sensitization Balb/c animals were
nti-IP-10, 40 Ag anti-Mig, or 63 Ag anti-CXCR3, ) or control IgG. A further
out mice received virus only (D). At 24 h post-challenge, ear pinna lysates
al data points are shown.
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bility for this is that these mice may have developed some
mechanism to compensate for the loss of CCR5. Alter-
natively, there may be more rapid or more abundant
expression of CXCR3 on the effector cells, or CXCR3
ligands may be expressed at higher levels than CCR5
ligands. It is interesting that Jiankuo et al. (2003) also
observed that CXCR3 was more dominant than CCR5 in
directing T cells into mouse skin allografts.
The finding that the DTH inflammatory response is not
completely ablated in the absence of either receptor (i.e.,
swelling remains significantly different from that observed
in unsensitized mice) or in IFN-g knockout mice strongly
suggests that additional receptors and ligands participate in
the DTH inflammatory cascade. For example, it has been
reported that the receptor CCR6 also can influence DTH
development (Varona et al., 2001).
IP-10 and Mig, ligands for CXCR3, were both found to
be elevated at the DTH site. We tested whether in vivo
neutralization of IP-10 or Mig would reduce ear swelling as
occurred with anti-CXCR3 treatment. Both antibodies
significantly suppressed DTH thereby confirming that
CXCR3/ligand biology plays an important role in the
recruitment of inflammatory cells to the site of viral antigen
deposition in skin. Interestingly, although the mean con-
centration of Mig in the ear pinna was N5 fold higher than
that of IP-10 the former did not compensate for neutraliza-
tion of the latter. Nor did IP-10 compensate when Mig was
neutralized. Thus, our results provide evidence that even
though these two chemokines bind to the same receptor,
they do not have redundant roles in DTH. This lack of
redundancy, while unexplained, has been observed in a
number of different inflammatory models (Dufour et al.,
2002; Fife et al., 2001; Hancock et al., 2001; Khan et al.,
2000; Koga et al., 1999; Liu et al., 2000, 2001b).
Our data suggest that IP-10 and Mig are important
recruiters of CD4+ T cells in viral antigen induced DTH.
Although CD8+ T cells were also recruited, they apparently
do not participate in DTH as CD8+ T cell depletion did not
diminish ear swelling (Tumpey et al., 2002) or lead to a
reduction in IP-10 or Mig levels (Molesworth-Kenyon and
Lausch, unpublished observations). CXCR3 has also been
reported to be expressed by additional murine leukocytes
including NK cells, NKT cells, and B cells (Johnston et al.,
2003; Soto et al., 1998; Trifilo et al., 2004). One or more of
these cell types could potentially contribute to the ear
swelling response. Further studies are needed to determine
whether CXCR3 expressing cells other than CD4+ T
lymphocytes participate in herpes virus antigen induced
DTH.
CXCR3 and its ligands have been associated with host
resistance to virus infection in a number of murine infection
models (Liu et al., 2000, 2001b; Mahalingam et al., 1999;
Salazar-Mather et al., 2000), and it has been speculated that
they may also play a role in limiting HSV-1 replication
(Lundberg and Cantin, 2003). However, we found thatneutralizing antibodies to IP-10, Mig, and CXCR3 did not
interfere with clearance of HSV-1 from the ear pinna of
sensitized hosts. This is in contrast to the work of Dufour et
al. (2002) in which an IP-10 gene-deficient mouse was
impaired in its ability to control mouse hepatitis virus
replication. One possible explanation is that at the time of
virus challenge, that is, 7 days after immunization, the
animals were actively producing anti-viral antibodies which
have been shown to inhibit HSV-1 replication in skin (van
Lint et al., 2004). Alternatively, one could speculate that the
effector cells that control HSV-1 replication in skin are
recruited by a distinctly different receptor-ligand combina-
tion. Our results do conform with earlier work which
indicated that DTH and virus clearance were independent
events (Lausch et al., 1987). Recently, Carr et al. (2003)
evaluated how neutralizing antibody to IP-10 affected
primary HSV-1 ocular infection. They found that antibody
treatment reduced leukocyte infiltration and ocular pathol-
ogy. However, there was only a transient and quite modest
increase (2- to 3-fold) in HSV-1 titer in the cornea and
trigeminal ganglion in the anti-IP-10 treated mice. It is
possible that recruitment of effector lymphocytes to control
HSV-1 replication in skin requires the participation of
chemokines involved in tissue-specific migration (Kunkel
and Butcher, 2002).
One of the hallmarks of Th1 cell mediated immune
responses is the expression of IFN-g (Mosmann and
Coffman, 1989). Our data show that this cytokine was
readily detected at the DTH site, and in agreement with a
previous report (Bouley et al., 1995), ear swelling is
substantially reduced in IFN-g gene knockout mice. We
further found that IP-10 and Mig were not detected in the
ear pinnae of these knockout mice. This strongly suggests
that IFN-g was required for their induction in vivo. We also
have found that depletion of CD4+ T cells but not CD8+
T cells reduced IFN-g levels in the ear pinna (Molesworth-
Kenyon and Lausch, unpublished observations), Thus,
CD4+ T cells are a likely source of IFN-g although NK
cells have not been ruled out. It has been observed that
mice unable to make IFN-g on primary corneal infection
displayed enhanced susceptibility to HSV-1 replication in
the eye (Bouley et al., 1995). However, our data show that
immunized as opposed to naive mice lacking IFN-g are
not impaired in their ability to contain challenge virus
replication. Presumably because the former have primed T
cells and specific antibodies at the time of HSV-1
challenge. Similarly, antibody neutralization of Mig and
IP-10 or their receptor did not impair HSV-1 clearance.
In summary, the results of this study establish CXCR3 and
its ligands as important contributors in DTH to a viral antigen.
The multifaceted cytokine IFN-g is also a significant player,
most likely functioning initially to stimulate resident skin
cells and/or infiltrating leukocytes including neutrophils to
produce IP-10 and Mig. These chemokines in turn recruit
CXCR3 bearing effector cells which collaborate with
CXCR2 expressing neutrophils to promote ear pinna
S. Molesworth-Kenyon et al. / Virology 333 (2005) 1–9 7inflammation. Further studies will refine this scenario and
provide insight into how virus replication is suppressed.Materials and methods
Animals
Six week old female Balb/c mice were obtained from
Taconic (Germantown, NY). Interferon gamma gene knock-
out (IFN-g/) mice on a Balb/c background, and wildtype
controls were obtained from Jackson Laboratories (Bar
Harbor, ME). Also CCR5/ mice on a C57 Bl/6 back-
ground and their controls were purchased from Jackson
Laboratories. All animals were cared for in accordance to
federal, state, and local regulations.
Antibodies and reagents
Polyclonal antibodies raised against mouse IP-10 (Goat
IgG) and mouse Mig (Goat IgG) were purchased from R&D
Systems, Inc. (Minneapolis, MN). Goat and rabbit immu-
noglobulin G were obtained from Jackson ImmunoResearch
Laboratories Inc. (West Grove, PA). The IgG fraction from a
rabbit polyclonal anti-mouse CXCR3 antibody was isolated
using a NAb Protein G Spin Chromatography Kit (Pierce,
Rockford, IL). Immunohistochemical staining of neutro-
phils, CD4+, and CXCR3+ cells was performed using rat
mAb RB6 8C5 (a gift from R. Coffman, DNAX Research
Institute, Palo Alto, CA), GK1.5 (ATCC, Manassas, VA),
and rabbit anti-CXCR3 antibodies, respectively. Appropri-
ate isotype controls were included.
Induction of DTH
Mice were sensitized with 1  104 PFU/2 Al HSV-1
strain RE on the scarified right cornea. The DTH response
was monitored using the ear swelling assay. In this model,
maximal swelling to HSV-1 antigen occurs at 24 h. Prior
studies have established that animals are DTH responsive 5
days post immunization and remain sensitized for weeks
(Lausch et al., 1985). DTH was elicited by injection of 10 Al
of RPMI 1640 medium + 5% newborn calf serum (NCS)
containing 1  105 PFU HSV-1 RE into the right ear pinna
using a 30-gauge needle and Hamilton syringe (Hamilton,
Reno, NV). The left ear received a control dose of medium
only. 24 h later, ear swelling was measured using a Mitutoyo
7326 Micrometer (Schlessinger Tools, New York, NY).
Results were expressed as the mean swelling of the virus
challenged ear minus the mean swelling of the control ear
(units 104 in.).
Chemokine neutralization
For chemokine neutralization experiments 36 Ag (low
dose) or 67 Ag (high dose) of anti-IP-10 or 40 Ag of anti-Mig antibody was admixed with 10 Al of virus challenge
dose. CXCR3 receptor blocking was achieved by admin-
istration of 63 Ag of anti-CXCR3 admixed with 10 Al of
virus challenge dose and a second injection of 70 Ag of anti-
CXCR3 antibody was given at the DTH site 11 h post-
challenge. In all cases, IgG controls were used at an
equivalent concentration to that of the antibodies.
Interferon and chemokine assay
Five mm2 ear sections from the DTH site were excised at
24 h post-challenged, homogenized, sonicated for 30 s and
clarified by centrifugation at 150  g for 10 min. Tissue
lysates were assayed for IP-10, Mig or IFN-g by using
ELISA kits purchased from R and D Systems Inc. The level
of sensitivity was 2.2 pg/ml, 3 pg/ml, and 2 pg/ml,
respectively.
Immunohistochemical staining
Mice were sensitized and challenged as described above.
Groups of mice were given 67 Ag of neutralizing antibody to
IP-10 or equivalent concentration of control IgG, admixed
with the virus challenge dose. 24 h later, 5 mm2 ear sections
were excised from the DTH site and imbedded in Tissue Tek
O.C.T. Compound (Sakura Finetek, Torrance, CA). Sections
(30 Am) were cut at 20 8C, fixed in ice-cold acetone for 5
min, air dried and blocked with 10% NCS. Sections were
stained for the presence of neutrophils (mAb RB6 8C5),
CD4+ (mAb GK1.5), and CXCR3+ (rabbit anti-CXCR3)
cells at 2 Ag/ml for 30 min at room temperature. Control
sections were treated with appropriate rat or rabbit isotype
controls (BD PharMingen, San Diego, CA). The sections
were then stained with goat-anti rat or rabbit FITC (BD
PharMingen, San Diego, CA) at a concentration of 1–10 Ag/
ml. Slides were washed in PBS and mounted with DAPI-
Vectashield (Vector Laboratories, Inc. Burlingame, CA) for
observation under the Leica TCS SPII confocal laser-
scanning microscope (Exton, PA). Section were counted in
a coded fashion, with the reader unaware of the treatment
given.
Virus titration
Tissue lysates from ear pinnae were assayed for virus
titer using a standard plaque assay on Vero monolayers.
Statistical analysis
Student’s t test was performed to determine significance
between DTH responses and chemokine production
between control and test groups. The level of confidence
for significance was P b 0.05. The data shown is
representative of individual experiments (mean F SEM
shown) with each experiment performed at least twice with
4–7 mice per group.
S. Molesworth-Kenyon et al. / Virology 333 (2005) 1–98Acknowledgment
This work was supported by NIH grant EY07564.References
Belperio, J.A., Keane, M.P., Burdick, M.D., Lynch III, J.P., Xue, Y.Y., Li,
K., Ross, D.J., Strieter, R.M., 2002. Critical role for CXCR3
chemokine biology in the pathogenesis of bronchiolitis obliterans
syndrome. J. Immunol. 169 (2), 1037–1049.
Bonecchi, R., Bianchi, G., Bordignon, P.P., D’Ambrosio, D., Lang, R.,
Borsatti, A., Sozzani, S., Allavena, P., Gray, P.A., Mantovani, A.,
Sinigaglia, F., 1998. Differential expression of chemokine receptors
and chemotactic responsiveness of type 1 T helper cells (Th1s) and
Th2s. J. Exp. Med. 187 (1), 129–134.
Bouley, D.M., Kanangat, S., Wire, W., Rouse, B.T., 1995. Characterization
of herpes simplex virus type-1 infection and herpetic stromal keratitis
development in IFN-gamma knockout mice. J. Immunol. 155 (8),
3964–3971.
Carr, D.J., Chodosh, J., Ash, J., Lane, T.E., 2003. Effect of anti-CXCL10
monoclonal antibody on herpes simplex virus type 1 keratitis and retinal
infection. J. Virol. 77 (18), 10037–10046.
Dufour, J.H., Dziejman, M., Liu, M.T., Leung, J.H., Lane, T.E., Luster,
A.D., 2002. IFNgamma-inducible protein 10 (IP-10; CXCL10)-defi-
cient mice reveal a role for IP-10 in effector T cell generation and
trafficking. J. Immunol. 168 (7), 3195–3204.
Farber, J.M., 1997. Mig and IP-10: CXC chemokines that target
lymphocytes. J. Leukocyte Biol. 61 (3), 246–257.
Fife, B.T., Kennedy, K.J., Paniagua, M.C., Lukacs, N.W., Kunkel, S.L.,
Luster, A.D., Karpus, W.J., 2001. CXCL10 (IFN-gamma-inducible
protein-10) control of encephalitogenic CD4+ T cell accumulation in
the central nervous system during experimental autoimmune encepha-
lomyelitis. J. Immunol. 166 (12), 7617–7624.
Flier, J., Boorsma, D.M., van Beek, P.J., Nieboer, C., Stoof, T.J., Willemze,
R., Tensen, C.P., 2001. Differential expression of CXCR3 targeting
chemokines CXCL10, CXCL9, and CXCL11 in different types of skin
inflammation. J. Pathol. 194 (4), 398–405.
Gasperini, S., Marchi, M., Calzetti, F., Laudanna, C., Vicentini, L., Olsen,
H., Murphy, M., Liao, F., Farber, J., Cassatella, M.A., 1999. Gene
expression and production of the monokine induced by IFN-gamma
(MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-
gamma-inducible protein-10 (IP-10) chemokines by human neutrophils.
J. Immunol. 162 (8), 4928–4937.
Hancock, W.W., Lu, B., Gao, W., Csizmadia, V., Faia, K., King, J.A.,
Smiley, S.T., Ling, M., Gerard, N.P., Gerard, C., 2000. Requirement of
the chemokine receptor CXCR3 for acute allograft rejection. J. Exp.
Med. 192 (10), 1515–1520.
Hancock, W.W., Gao, W., Csizmadia, V., Faia, K.L., Shemmeri, N., Luster,
A.D., 2001. Donor-derived IP-10 initiates development of acute
allograft rejection. J. Exp. Med. 193 (8), 975–980.
Hendricks, R.L., Tumpey, T.M., 1990. Contribution of virus and immune
factors to herpes simplex virus type I-induced corneal pathology. Invest.
Ophthalmol. Visual Sci. 31 (10), 1929–1939.
Jiankuo, M., Xingbing, W., Baojun, H., Xiongwin, W., Zhuoya, L., Ping,
X., Yong, X., Anting, L., Chunsong, H., Feili, G., Jinquan, T., 2003.
Peptide nucleic acid antisense prolongs skin allograft survival by
means of blockade of CXCR3 expression directing T cells into graft.
J. Immunol. 170 (3), 1556–1565.
Johnston, B., Kim, C.H., Soler, D., Emoto, M., Butcher, E.C., 2003.
Differential chemokine responses and homing patterns of murine TCR
alpha beta NKT cell subsets. J. Immunol. 171 (6), 2960–2969.
Khan, I.A., MacLean, J.A., Lee, F.S., Casciotti, L., DeHaan, E., Schwartz-
man, J.D., Luster, A.D., 2000. IP-10 is critical for effector T cell
trafficking and host survival in Toxoplasma gondii infection. Immunity
12 (5), 483–494.Klunker, S., Trautmann, A., Akdis, M., Verhagen, J., Schmid-Grendel-
meier, P., Blaser, K., Akdis, C.A., 2003. A second step of chemotaxis
after transendothelial migration: keratinocytes undergoing apoptosis
release IFN-gamma-inducible protein 10, monokine induced by IFN-
gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell
chemotaxis toward epidermis in atopic dermatitis. J. Immunol. 171 (2),
1078–1084.
Koga, S., Auerbach, M.B., Engeman, T.M., Novick, A.C., Toma, H.,
Fairchild, R.L., 1999. T cell infiltration into class II MHC-disparate
allografts and acute rejection is dependent on the IFN-gamma-induced
chemokine Mig. J. Immunol. 163 (9), 4878–4885.
Kudo, C., Yamashita, T., Terashita, M., Sendo, F., 1993. Modulation of in
vivo immune response by selective depletion of neutrophils using a
monoclonal antibody, RP-3: II. Inhibition by RP-3 treatment of
mononuclear leukocyte recruitment in delayed-type hypersensitivity to
sheep red blood cells in rats. J. Immunol. 150 (9), 3739–3746.
Kunkel, E.J., Butcher, E.C., 2002. Chemokines and the tissue-specific
migration of lymphocytes. Immunity 16 (1), 1–4.
Kunkel, E.J., Boisvert, J., Murphy, K., Vierra, M.A., Genovese, M.C.,
Wardlaw, A.J., Greenberg, H.B., Hodge, M.R., Wu, L., Butcher, E.C.,
Campbell, J.J., 2002. Expression of the chemokine receptors CCR4,
CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am. J.
Pathol. 160 (1), 347–355.
Larsen, C.G., Thomsen, M.K., Gesser, B., Thomsen, P.D., Deleuran, B.W.,
Nowak, J., Skodt, V., Thomsen, H.K., Deleuran, M., Thestrup-
Pedersen, K., et al., 1995. The delayed-type hypersensitivity reaction
is dependent on IL-8. Inhibition of a tuberculin skin reaction by an anti-
IL-8 monoclonal antibody. J. Immunol. 155 (4), 2151–2157.
Lausch, R.N., Kleinschradt, W.R., Monteiro, C., Kayes, S.G., Oakes,
J.E., 1985. Resolution of HSV corneal infection in the absence of
delayed-type hypersensitivity. Invest. Ophthalmol. Visual Sci. 26 (11),
1509–1515.
Lausch, R.N., Monteiro, C., Kleinschrodt, W.R., Oakes, J.E., 1987.
Superiority of antibody versus delayed hypersensitivity in clear-
ance of HSV-1 from eye. Invest. Ophthalmol. Visual Sci. 28 (3),
565–570.
Liu, M.T., Chen, B.P., Oertel, P., Buchmeier, M.J., Armstrong, D.,
Hamilton, T.A., Lane, T.E., 2000. The T cell chemoattractant IFN-
inducible protein 10 is essential in host defense against viral-induced
neurologic disease. J. Immunol. 165 (5), 2327–2330.
Liu, M.T., Armstrong, D., Hamilton, T.A., Lane, T.E., 2001a.
Expression ofMig (monokine induced by interferon-gamma) is important
in T lymphocyte recruitment and host defense following viral infection of
the central nervous system. J. Immunol. 166 (3), 1790–1795.
Liu, M.T., Keirstead, H.S., Lane, T.E., 2001b. Neutralization of the
chemokine CXCL10 reduces inflammatory cell invasion and demyeli-
nation and improves neurological function in a viral model of multiple
sclerosis. J. Immunol. 167 (7), 4091–4097.
Loetscher, P., Uguccioni, M., Bordoli, L., Baggiolini, M., Moser, B.,
Chizzolini, C., Dayer, J.M., 1998. CCR5 is characteristic of Th1
lymphocytes. Nature 391 (6665), 344–345.
Lu, B., Humbles, A., Bota, D., Gerard, C., Moser, B., Soler, D., Luster,
A.D., Gerard, N.P., 1999. Structure and function of the murine
chemokine receptor CXCR3. Eur. J. Immunol. 29 (11), 3804–3812.
Lundberg, P., Cantin, E., 2003. A potential role for CXCR3 chemokines
in the response to ocular HSV infection. Curr. Eye Res. 26 (3–4),
137–150.
Mahalingam, S., Farber, J.M., Karupiah, G., 1999. The interferon-inducible
chemokines MuMig and Crg-2 exhibit antiviral activity in vivo. J. Virol.
73 (2), 1479–1491.
Mosmann, T.R., Coffman, R.L., 1989. TH1 and TH2 cells: different
patterns of lymphokine secretion lead to different functional properties.
Annu. Rev. Immunol. 7, 145–173.
Nash, A.A., Gell, P.G., 1983. Membrane phenotype of murine effector
and suppressor T cells involved in delayed hypersensitivity and
protective immunity to herpes simplex virus. Cell. Immunol. 75 (2),
348–355.
S. Molesworth-Kenyon et al. / Virology 333 (2005) 1–9 9Newell, C.K., Martin, S., Sendele, D., Mercadal, C.M., Rouse, B.T., 1989.
Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte
subsets in immunopathology. J. Virol. 63 (2), 769–775.
Salazar-Mather, T.P., Hamilton, T.A., Biron, C.A., 2000. A chemokine-
to-cytokine-tochemokine cascade critical in antiviral defense. J. Clin.
Invest. 105 (7), 985–993.
Sallusto, F., Lenig, D., Mackay, C.R., Lanzavecchia, A., 1998.
Flexible programs of chemokine receptor expression on human polarized
T helper 1 and 2 lymphocytes. J. Exp. Med. 187 (6), 875–883.
Schrier, R.D., Pizer, L.I., Moorhead, J.W., 1982. Delayed hypersensitivity to
herpes simplex virus: murine model. Infect. Immun. 35 (2), 566–571.
Soto, H., Wang, W., Strieter, R.M., Copeland, N.G., Gilbert, D.J., Jenkins,
N.A., Hedrick, J., Zlotnik, A., 1998. The CC chemokine 6Ckine binds
the CXC chemokine receptor CXCR3. Proc. Natl. Acad. Sci. U. S. A.
95 (14), 8205–8210.
Tokuriki, A., Seo, N., Ito, T., Kumakiri, M., Takigawa, M., Tokura, Y.,
2002. Dominant expression of CXCR3 is associated with induced
expression of IP-10 at hapten-challenged sites of murine contact
hypersensitivity: a possible role for interferon-gamma-producing
CD8(+) T cells in IP-10 expression. J. Dermatol. Sci. 28 (3), 234–241.
Trifilo, M.J., Montalto-Morrison, C., Stiles, L.N., Hurst, K.R., Hardison,
J.L., Manning, J.E., Masters, P.S., Lane, T.E., 2004. CXC chemokineligand 10 controls viral infection in the central nervous system:
evidence for a role in innate immune response through recruitment
and activation of natural killer cells. J. Virol. 78 (2), 585–594.
Tumpey, T.M., Fenton, R., Molesworth-Kenyon, S., Oakes, J.E., Lausch,
R.N., 2002. Role for macrophage inflammatory protein 2 (MIP-2),
MIP-1alpha, and interleukin-1alpha in the delayed-type hypersensitivity
response to viral antigen. J. Virol. 76 (16), 8050–8057.
van Lint, A., Ayers, M., Brooks, A.G., Coles, R.M., Heath, W.R., Carbone,
F.R., 2004. Herpes simplex virus-specific CD8+ T cells can clear
established lytic infections from skin and nerves and can partially limit
the early spread of virus after cutaneous inoculation. J. Immunol. 172
(1), 392–397.
Varona, R., Villares, R., Carramolino, L., Goya, I., Zaballos, A., Gutierrez,
J., Torres, M., Martinez, A.C., Marquez, G., 2001. CCR6-deficient mice
have impaired leukocyte homeostasis and altered contact hypersensi-
tivity and delayed-type hypersensitivity responses. J. Clin. Invest. 107
(6), R37–R45.
Xie, J.H., Nomura, N., Lu, M., Chen, S.L., Koch, G.E., Weng, Y., Rosa, R.,
Di Salvo, J., Mudgett, J., Peterson, L.B., Wicker, L.S., DeMartino, J.A.,
2003. Antibody-mediated blockade of the CXCR3 chemokine receptor
results in diminished recruitment of T helper 1 cells into sites of
inflammation. J. Leukocyte Biol. 73 (6), 771–780.
